EIF2S2 and hepatocellular carcinoma: In addition, EIF2S2 is also associated with immune cell infiltration and immune checkpoint, which can become a potential therapeutic approach, bringing new hope for the clinical treatment of HCC (AuthorAnonymous et al., 2022).